Micron, Oracle are new Top Picks at Mizuho
Mizuho analysts updated their Top Picks List, adding Micron (NASDAQ:MU) and Oracle (NYSE:ORCL) to the roster. Other stocks that were added as a part of the September update are Coterra Energy (NYSE:CT...
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
| 7.81 | |
| 7.6 | |
| - | |
| 7.99 | |
| 7.03 | |
| 3.26-10.03 | |
| 550 M | |
| 70 372 K | |
| 1 000 K | |
| -0.31 | |
| -0.384 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Mizuho analysts updated their Top Picks List, adding Micron (NASDAQ:MU) and Oracle (NYSE:ORCL) to the roster. Other stocks that were added as a part of the September update are Coterra Energy (NYSE:CT...
Investing in biotech stocks is a thrilling ride. These innovative businesses developing breakthrough drugs can generate enormous profits for investors but also destroy significant value if their inves...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: